(Q42638844)

4 November 2017

title

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium (English)

1 reference

4 November 2017

1 reference

1 reference

3

Christine Galant

1 reference

4 November 2017

Julie Ducreux

1

1 reference

4 November 2017

Patrick Durez

2

1 reference

4 November 2017

Adrien Nzeusseu Toukap

4

1 reference

4 November 2017

Benoît Van den Eynde

5

1 reference

4 November 2017

Frédéric A Houssiau

6

1 reference

4 November 2017

Bernard R Lauwerys

7

1 reference

4 November 2017

publication date

1 January 2014

1 reference

4 November 2017

published in

Arthritis & Rheumatology

1 reference

4 November 2017

volume

66

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

15-23

1 reference

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

4 November 2017

cites work

1 reference

21 January 2018

1 reference

Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis

21 January 2018

1 reference

Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

Quantitative biomarker analysis of synovial gene expression by real-time PCR

21 January 2018

1 reference

How to perform and analyse synovial biopsies

21 January 2018

1 reference

Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.

21 January 2018

1 reference

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

Interleukin-6 and rheumatic diseases

21 January 2018

1 reference

Synergistic activation of human T cells by interleukin 1 and interleukin 6

21 January 2018

1 reference

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis

21 January 2018

1 reference

A systems approach to rheumatoid arthritis

21 January 2018

1 reference

Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis

21 January 2018

1 reference

Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

21 January 2018

1 reference

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

21 January 2018

1 reference

The anti-CD20 antibody rituximab reduces the Th17 cell response

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.38202

1 reference

4 November 2017

1 reference